By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Royalty Pharma 

110 East 59th Street
33rd Floor
New York  New York  10022  U.S.A.
Phone: (212)-883-0200 Fax: (212) 883-2260




Company News
Cytokinetics (CYTK) Grabs a $100 Million Deal for Heart Drug With Royalty Pharma 2/2/2017 6:02:53 AM
UCLA Sells Royalty Rights Connected with Cancer Drug to Royalty Pharma for $1.14 Billion 3/4/2016 8:55:53 AM
Royalty Pharma Announces George Lloyd Is Named General Counsel 2/12/2015 7:37:10 AM
Royalty Pharma Partners With Aisling Capital and Clarus Ventures in Recent Ibrutinib Royalty Purchase 8/12/2013 9:51:30 AM
Royalty Pharma Announces Marshall Urist, MD, PhD, Joins Management Team 7/19/2013 6:28:35 AM
Quest Diagnostics Inc. (DGX) Sells Ibrutinib Royalty Rights to Royalty Pharma for $485 Million in Cash 7/18/2013 7:03:21 AM
Game May Not be Over for Royalty Pharma's Bid for Elan Corporation PLC (ELN) 6/28/2013 7:25:07 AM
Royalty Pharma Drops Hostile Bid for Elan Corporation PLC (ELN) 6/18/2013 7:21:41 AM
Royalty Pharma Informs Elan Corporation PLC (ELN) Stockholders About the Consequences Arising From the Results of the Elan EGM Earlier Today 6/17/2013 11:44:17 AM
Royalty Pharma Chairman Writes Open Letter to Elan Corporation PLC (ELN) Board 6/17/2013 8:59:54 AM